Non-Pharmacological Interventions in Refractory Angina
DOI:
https://doi.org/10.17140/HROJ-5-146Keywords:
Refractory angina (RA), Enhanced external counterpulsation (EECP), Cardiac rehabilitationAbstract
Refractory angina (RA) is defined by intractable cardiac chest pain despite standard medical therapy and revascularisation. Symptoms
are associated with significant morbidity and compromised quality of life (QoL). Various methods of interventional pain
management can be considered for the complex care of these cohorts. This review explores postulated mechanisms and evidence
base underpinning therapeutic strategies such as cognitive behavioural therapy (CBT), cardiac rehabilitation, stellate ganglion blockade
(SGB), enhanced external counterpulsation (EECP) and coronary sinus reducer (CSR) implantation. Use of these modalities is
dependent on the local provision, but suitability is best assessed by specialist RA services using an individualised, multidisciplinary
framework.
References
Mannheimer C, Camici P, Chester MR, et al. The problem of chronic refractory angina; report from the ESC Joint Study Group on the Treatment of Refractory Angina. Eur Heart J. 2002; 23: 335- 370. doi: 10.1053/euhj.2001.2706
Banai S, Ben Muvhar S, Parikh KH, et al. Coronary sinus reducer stent for the treatment of chronic refractory angina pectoris. J Am Coll Cardiol. 2007; 49: 1783-1789. doi: 10.1016/j. jacc.2007.01.061
Moore RKG, Groves DG, Bridson JD, et al. A brief cognitive-behavioural intervention reduces hospital admissions in refractory angina patients. J Pain Symptom Manage. 2007; 33: 310-316. doi: 10.1016/j.jpainsymman.2006.10.009
Henry TD, Satran D, Hodges JS, et al. Long-term survival in patients with refractory angina. Eur Heart J. 2013; 34: 2683-2688. doi: 10.1093/eurheartj/eht165
European Society of Cardiology guidelines for the management of stable coronary artery disease: The Task Force on the manage-ment of stable coronary artery disease of the European Society of Cardiology (ESC). Eur Heart J. 2013; 34: 2949-3003. doi: 10.1093/ eurheartj/eht296
Psotka MA, Teerlink JR. Ivabradine: Role in the chronic heart failure Armamentarium. Circulation. 2016; 133(21): 2066-2075. doi: 10.1161/CIRCULATIONAHA.115.018094
Keating GM. Ranolazine: A review of its use as add-on therapy in patients with chronic stable angina pectoris. Drugs. 2013; 73(1): 55-73. doi: 10.1007/s40265-012-0005-z
Hasenfussand G, Maier LS. Mechanism of action of the new anti-ischemia drug ranolazine. Clin Res Cardiol. 2008; 97(4): 222- 226. doi: 10.1007/s00392-007-0612-y
Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization. Eur Heart J. 2010; 31: 2501-2555. doi: 10.1016/j. ejcts.2010.08.019
McGillion M, Arthur H, Victor JC, et al. Effectiveness of Review | Volume 5 | Number 1| Ali N, et al psychoeducational interventions for improving symptoms, health-related quality of life, and psychological well-being in patients with stableangina. Curr Cardiol Rev. 2008; 4: 1-11. doi: 10.2174/157340308783565393
Patel PA, Khan M, Yau C, et al. The short- and long-term im-pact of psychotherapy in patients with chronic, refractory angina. Br J Cardiol. 2016; 23: 57-60. doi: 10.5837/bjc.2016.019
Pak N, Devcich DA, Johnson MH, et al. Is refractory angina pectoris a form of chronic pain? A comparison of two patient groups receiving spinal cord stimulation therapy. N Z Med J. 2014; 127(1391): 52-61.
La Cour P, Petersen M. Effects of mindfulness medication on chronic pain: A randomized controlled trial. Pain Med. 2015; 16(4): 641-652. doi: 10.1111/pme.12605
Asbury EA, Webb CM, Probert H, et al. Cardiac rehabilitation to improve physical functioning in refractory angina: A pilot study. Cardiology. 2012; 122: 170-177. doi: 10.1159/000339224
Drummond PD, Finch PM, Skipworth S, et al. Pain increas-es during sympathetic arousal in patients with complex regional pain syndrome. Neurology. 2001; 57(7): 1296-1303. doi: 10.1212/ WNL.57.7.1296
Meller ST, Gebhart GF. A critical review of the afferent pathways and the potential chemical mediators involved in car-diac pain. Neuroscience. 1992; 48(3): 501-524. doi: 10.1016/0306- 4522(92)90398-L
Gask GE. The surgery of the sympathetic nervous system. Br J Surg. 1993; 21: 113-130.
Stanton-Hicks M. Complications of sympathetic blocks for extremity pain. Tech Reg Anesth Pain Manage. 2007; 11(3): 148-151.
Wiener L, Cox JW. Influence of stellate ganglion block on an-gina pectoralis and the post-exercise electrocardiogram. Am J Med Sci. 1966; 252(3): 289-295.
Moore R, Groves D, Hammond C, et al. Temporary sympa-thectomy in the treatment of chronic refractory angina. J Pain Symptom Manage. 2005; 30(2): 183-191. doi: 10.1016/j.jpainsym-man.2005.02.016
Chester M, Hammond C, Leach A. Long-term benefits of stel-late ganglion block in severe chronic refractory angina. Pain. 2000; 87(1): 103-105.
Arora RR, Shah AG. The role of enhanced external counter-pulsation in the treatment of angina and heart failure. Can J Cardiol. 2007; 23(10): 779-781.
Arora RR, Chou TM, Jain D, et al. The multicenter study of enhanced external counterpulsation (MUST-EECP): Effect of EECP on exercise-induced myocardial ischemia and anginal ep-isodes. J Am Coll Cardiol. 1999; 33(7): 1833-1840. doi: 10.1016/ S0735-1097(99)00140-0
Zhang C, Liu X, Wang X, et al. Efficacy of enhanced exter-nal counterpulsation in patients with chronic refractory angina on canadian cardiovascular society (CCS) angina class. Medicine (Bal-timore). 2015; 94(47): 2002. doi: 10.1097/MD.0000000000002002
Barsness G, Feldman AM, Holmes DR Jr., et al. The interna-tional EECP patient registry (IEPR): Design, methods, baseline characteristics, and acute results. Clin Cardiol. 2001; 24(6): 435-442. doi: 10.1002/clc.4960240604
Qin X, Deng Y, Wu D, et al. Does enhanced external counter-pulsation (EECP) significantly affect myocardial perfusion?: A sys-tematic review & meta- analysis. PLoS One. 2016; 11(4): e0151822. doi: 10.1371/journal.pone.0151822
Lawson WE, Hui JC, Kennard ED, et al. Enhanced external counterpulsation is cost-effective in reducing hospital costs in refractory angina patients. Clin Cardiol. 2015; 38(6): 344-349. doi: 10.1002/clc.22395
Masuda D, Nohara R, Hirai T, et al. Enhanced external coun-terpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina; Evaluation by 13N-ammonia positron emission tomography. Eur Heart J. 2001; 22: 1451-1458. doi: 10.1053/euhj.2000.2545
Masuda D, Nohara K, Kataoka K, et al. Enhanced external counterpulsation promotes angiogenesis factors in patients with chronic stable angina. Circulation. 2001; 104: II445. doi: 10.1053/ euhj.2000.2545
Bonetti PO, Barsness GW, Keelan PC, et al. Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. J Am Coll Cardiol. 2003; 41: 1761-1768. doi: 10.1016/S0735-1097(03)00329-2
Braith RW, Conti CR, Nichols WW, et al. Enhanced external counterpulsation improves peripheral artery flow mediated dila-tation in patients with chronic angina: A randomized sham-con-trolled study. Circulation. 2010; 122: 1612-1620. doi: 10.1161/CIR-CULATIONAHA.109.923482
Davies PF. Flow-mediated endothelial mechanotransduction. Physiol Rev. 1995; 75: 519-560.
Eslamian F, Aslanabadi N, Mahmoudian B, et al. Therapeutic effects of enhanced external counterpulsation on clinical sump-toms, echocardiographic measurements, perfusion scan param-eters and exercise tolerance test in coronary artery disease patients with refractory angina. Int J Med Sci Public Health. 2013; 2: 179-187.
Verheye S, Jolicoeur EM, Behan MW, et al. Efficacy of a device to narrow the coronary sinus in refractory angina. N Engl J Med. 2015; 372(6): 519-527. 6 Ali N, et al
Beck CS, Leighninger DS. Operations for coronary artery disease. J Am Med Assoc. 1954; 156: 1226-1233. doi: 10.1001/ jama.1954.02950130006002
Beck CS, Leighninger DS. Scientific basis for the surgical treat-ment of coronary artery disease. J Am Med Assoc. 1955; 159: 1264- 1271. doi: 10.1001/jama.1955.02960300008003
Sandler G, Slesser BV, Lawson CW. The Beck operation in the treatment of angina pectoris. Thorax. 1967; 22: 34-37.
Wising PJ. The Beck-1 operation for angina pectoris: Medi-cal aspects. Acta Med Scand. 1963; 174: 93-98. doi: 10.1111/j.0954- 6820.1963.tb07895.x
Brofman BL. Medical evaluation of the Beck operation for coronary artery disease. J Am Med Assoc. 1956; 162: 1603-1606.doi: 10.1001/jama.1956.02970350019005
Crea F, Galassi AR, Kaski JC, et al. Effect of theophylline on exercise-induced myocardial ischemia. Lancet. 1989; 1: 683-686. doi: 10.1016/S0140-6736(89)92204-6
Benedetto D, Abawi M, Stella PR, et al. Percutaneous device to narrow the coronary sinus: Shifting paradigm in the treatment of refractory angina? A review of the literature. Front Cardiovasc Med. 2016; 3: 42. doi: 10.3389/fcvm.2016.00042
Ido A, Hasebe N, Matsuhashi H, et al. Coronary sinus occlu-sion enhances coronary collateral flow and reduces subendocardial ischemia. Am J Physiol Heart Circ Physiol. 2001; 280: H1361-H1367. doi: 10.3389/fcvm.2016.00042
Konigstein M, Meyten N, Verheye S, et al. Transcatheter treat-ment for refractory angina with the coronary sinus reducer. Euro-Intervention. 2014; 9(10): 1158-1164. doi: 10.4244/EIJV9I10A196
Banai S, Muvhar BS, Parikh KH, et al. Coronary sinus reduc-er stent for the treatment of chronic refractory angina pectoris: A prospective, open-label, multicenter, safety feasibility first-in-man study. J Am Coll Cardiol. 2007; 49: 1783-1789. doi: 10.1016/j. jacc.2007.01.061
REDUCER-I: An Observational Study of the Neovasc Reduc-er™ System (2016). Web site. http://clinicaltrials.gov/ct2. (Identi-fication No. NCT02710435).
Melzack R, Wall PD. Pain mechanisms: A new theory. Science. 1965; 150: 971-979. doi: 10.1126/science.150.3699.971
Eddicks S, Maier-Hauff K, Schenk M, et al. Thoracic spinal cord stimulation improves functional status and relieves symptoms in patients with refractory angina pectoris: The first placebo con-trolled randomized study. Heart. 2007; 93: 585-590.
Lanza G, Grimaldi R, Greco S, et al. Spinal cord stimulation for the treatment of refractory angina pectoris: A multicenter random-ized single-blind study (the SCS-ITA trial). Pain. 2011; 152: 45-52. Review | Volume 5 | Number 1| doi: 10.1016/j.pain.2010.08.044
Zipes D, Svorkdal N, Berman D, et al. C. Spinal cord stimula-tion therapy for patients with refractory angina who are not candi-dates for revascularization. Neuromodulation. 2012; 15: 550-558. doi: 10.1111/j.1525-1403.2012.00452.x
West PD, Colquhoun DM. TENS in refractory angina pectoris. Three case reports. Med J Aust. 1993; 158(7): 488-489.
Schmid JP, Capoferri M, Wahl A, et al. Cardiac shock wave therapy for chronic refractory angina pectoris. A prospective place-bo-controlled randomized trial. Cardiovasc Ther. 2013; 31(3): e1-e6. doi: 10.1111/j.1755-5922.2012.00313.x
Przyklenk K, Bauer B, Ovize M, et al. Regional ischemic ‘pre-conditioning’ protects remote virgin myocardium from subsequent Submit your article to this journal | https://openventio.org/submit-manuscript/ Review | Volume 5 | Number 1| Ali N, et al sustained coronary occlusion. Circulation. 1993; 87(3): 893-899. doi: 10.1161/01.CIR.87.3.893
Effect of Daily Remote Ischemic Conditioning on the Life Quality of Refractory Angina Pectoris Patients (D-RIC-RAP) (2015). Web site. http://clinicaltrials.gov/ct2. (Identification No. NCT02499250).
Moore RK, Groves D, Bateson S, et al. Health related quality of life of patients with refractory angina before and one year after enrolment onto a refractory angina program. Eur J Pain. 2005; 9: 305-310. doi: 10.1016/j.ejpain.2004.07.013
Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/ AATS/PCNA/SCAI/STS guideline for the diagnosis and man-agement of patients with stable ischemic heart disease. J Am Coll Cardiol. 2012; 60(24): e44-e164. doi: 10.1016/j.jacc.2012.07.013
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Heart Research (HROJ) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.